Sichuan Huiyu Pharmaceutical Co Ltd (688553) - Total Liabilities

Latest as of September 2025: CN¥1.16 Billion CNY ≈ $169.05 Million USD

Based on the latest financial reports, Sichuan Huiyu Pharmaceutical Co Ltd (688553) has total liabilities worth CN¥1.16 Billion CNY (≈ $169.05 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 688553 cash flow conversion to assess how effectively this company generates cash.

Sichuan Huiyu Pharmaceutical Co Ltd - Total Liabilities Trend (2017–2024)

This chart illustrates how Sichuan Huiyu Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Sichuan Huiyu Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.

Sichuan Huiyu Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Sichuan Huiyu Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Bright Real Estate Group Co Ltd SHG:600708	China	CN¥48.15 Billion
BLS International Services Limited NSE:BLS	India	Rs9.00 Billion
Metropolitan Kentjana Tbk JK:MKPI	Indonesia	Rp2.24 Trillion
Shenzhen Shenbao Industrial Co Ltd SHE:000019	China	CN¥2.02 Billion
Superloop Ltd AU:SLC	Australia	AU$241.95 Million
Ambea AB ST:AMBEA	Sweden	Skr15.28 Billion
Playtika Holding Corp NASDAQ:PLTK	USA	$3.76 Billion
Corbion NV AS:CRBN	Netherlands	€727.30 Million

Liability Composition Analysis (2017–2024)

This chart breaks down Sichuan Huiyu Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Sichuan Huiyu Pharmaceutical Co Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.85	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.31	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sichuan Huiyu Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sichuan Huiyu Pharmaceutical Co Ltd (2017–2024)

The table below shows the annual total liabilities of Sichuan Huiyu Pharmaceutical Co Ltd from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.19 Billion ≈ $174.46 Million	+30.84%
2023-12-31	CN¥911.22 Million ≈ $133.34 Million	+63.17%
2022-12-31	CN¥558.44 Million ≈ $81.72 Million	-2.20%
2021-12-31	CN¥571.01 Million ≈ $83.56 Million	+23.79%
2020-12-31	CN¥461.26 Million ≈ $67.50 Million	+2.20%
2019-12-31	CN¥451.33 Million ≈ $66.04 Million	-7.89%
2018-12-31	CN¥490.02 Million ≈ $71.71 Million	+16.14%
2017-12-31	CN¥421.94 Million ≈ $61.74 Million	--

About Sichuan Huiyu Pharmaceutical Co Ltd

SHG:688553 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.24 Billion

CN¥8.46 Billion CNY

Market Cap Rank

#8202 Global

#2080 in China

Share Price

CN¥19.98

Change (1 day)

+2.41%

52-Week Range

CN¥13.59 - CN¥27.61

All Time High

CN¥38.07